3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Phase 1/2
2
Phase 4
1
Phase 3
1
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Metastatic Castration-resistant Prostate Cancer
1
Interventions
Specimen Handling
108
Magnetic Resonance Spectroscopy
77
Biopsy
76
pembrolizumab
59
Cyclophosphamide
49
fludarabine
40
Carboplatin
25
Nivolumab
24
Cetuximab
23
venetoclax
21
Radiotherapy
21
Cisplatin
21
Bevacizumab
20
atezolizumab
18
X-Rays
18
Radiation
17
Ipilimumab
17
fludarabine phosphate
16
Fluorouracil
16
Gemcitabine
15
Temozolomide
14
Paclitaxel
14
Leucovorin
14
Irinotecan
14
Cytarabine
14
durvalumab
13
Pemetrexed
13
Azacitidine
13
Oxaliplatin
12
CTLA-4 Antigen
12
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
radium Ra 223 dichloride
×
30 days
×
Clear all
NCT04109729
2026-06-01
Rad2Nivo
University of Utah
Phase 1
Active not recruiting
39 enrolled